Intra-aortic balloon pumping in children with dilated cardiomyopathy as a bridge to transplantation

Area of Science:

• Pediatric Cardiology
• Mechanical Circulatory Support
• Cardiomyopathy Research

Background:

• Dilated cardiomyopathy is a serious condition in children, often requiring heart transplantation.
• Pharmacologic therapy is the first line of treatment, but some children do not respond adequately.
• Advanced mechanical support may be necessary for children awaiting transplantation.

Purpose of the Study:

• To evaluate the efficacy and safety of intra-aortic balloon pumping (IABP) as a bridge to heart transplantation in children with dilated cardiomyopathy.
• To determine if IABP can provide sufficient hemodynamic support for pediatric patients refractory to maximal medical management.

Main Methods:

• A retrospective review of 4 pediatric patients with dilated cardiomyopathy who underwent IABP between July 1993 and August 1999.
• Patients received IABP support for a mean duration of 6.0 +/- 5.8 days (range: 1-12 days).
• IABP was precisely timed with M-mode echocardiographic markers for optimal support.

Main Results:

• Three out of four children (75%) successfully received heart transplants after IABP support.
• One patient who received IABP for 12 days unfortunately died while awaiting transplantation.
• IABP provided a feasible and safe intermediate mechanical support option.

Conclusions:

• Intra-aortic balloon pumping serves as a viable mechanical circulatory support option for pediatric patients with dilated cardiomyopathy awaiting transplantation.
• This approach is particularly beneficial for children who fail to achieve adequate hemodynamic stability with maximal pharmacologic therapy.
• IABP, when timed with echocardiographic guidance, offers a relatively simple and safe bridge to transplant in this critical population.